Legendary “60 Minutes” correspondent Scott Pelley launched an astonishing on-air attack on his Paramount bosses for interfering with the program’s coverage. Pelley went rogue at the end of ...

Travis Scott turned up at Coachella earlier this month, and unfortunately for the festival organizers, his performance has lightened their bank account by $20,000. That may seem like a big amount ...

Republican Michael Henry said he’s raising the necessary funds for a rematch bid to topple embattled New York State Attorney General Letitia James next year. Henry — who ran a spirited bid ...

Kendra Scott (4) Still searching for the perfect Mother’s Day gift? We’ve got just the right thing — er, bling — for you. Kendra Scott, a brand sported by Kate Hudson and Michelle Obama is ...

“Rule of Law Shock and Awe”: Norm Eisen’s Legal War on Trump and Musk Lawyer Norm Eisen talks with TNR editor Michael Tomasky about the dozens of anti-Trump lawsuits he’s involved with ...

As the second antibody-drug conjugate launched by Daiichi Sankyo and AstraZeneca, Datroway has a tough act to follow, coming on the heels of the companies’ emerging ADC cancer powerhouse Enhertu.

Scott Neuman is a correspondent for NPR's Enterprise Desk, based in Washington, D.C. He joined the network in 2007 as a breaking news editor and reporter, but has since moved into writing longer ...

located in 49 states and containing approximately 47.2 million square feet of gross leasable area. The Company's common stock is listed on the New York Stock Exchange under the symbol "ADC".

says NCR columnist Michael Sean Winters. The cardinals will want to find a new pope committed to Francis' vision of a church. The real question is whether the majority will want someone who is ...

Welcome to Nat Geo Your Shot: National Geographic’s global community for aspiring visual storytellers. Find the community on Instagram @NatGeoYourShot and follow along for hashtag challenges ...

The phase 1b trial is investigating the ADC and Keytruda – with or without chemo – in both previously-untreated and pretreated patients with advanced NSCLC who don’t have genetic mutations ...